Revenue
2010
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.40B | $9.91B | $9.46B | $8.72B | $8.29B | $6.83B | $7.51B | $7.18B | $6.50B | $6.29B | $5.60B |
| Gross profit | $5.75B | $5.51B | $5.25B | $4.75B | $4.65B | $2.94B | $3.66B | $5.50B | $4.88B | $4.82B | $4.20B |
| Research & development | $990.0M | $876.0M | $828.0M | $702.0M | $842.0M | $673.0M | $656.0M | $747.0M | $665.0M | $619.0M | $564.0M |
| Operating income | $1.36B | $1.41B | $1.04B | $672.0M | $580.0M | −$482.0M | −$187.0M | $2.48B | $2.26B | $2.21B | $1.88B |
| EBITDAderived | — | — | $2.17B | $1.66B | $1.49B | $889.0M | $1.16B | $2.75B | $2.48B | $2.41B | $2.09B |
| Net income | $980.0M | $1.02B | $974.0M | $335.0M | $376.0M | −$531.0M | −$656.0M | $2.21B | $2.01B | $2.05B | $1.59B |
| Basic EPSper diluted share | $1.99 | $2.06 | $1.98 | $0.68 | $0.77 | -$1.09 | -$1.34 | $7.34 | $6.72 | $6.86 | $5.32 |
| Diluted EPSper diluted share | $1.98 | $2.05 | $1.96 | $0.68 | $0.76 | -$1.09 | -$1.34 | $7.27 | $6.66 | $6.79 | $5.25 |